Growth Metrics

Trulieve Cannabis (TCNNF) Gains from Investment Securities (2020 - 2026)

Trulieve Cannabis has reported Gains from Investment Securities over the past 6 years, most recently at $17.4 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 247.52% year-over-year to $17.4 million; the TTM value through Dec 2025 reached $1.5 million, up 103.02%, while the annual FY2025 figure was $1.5 million, 103.02% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $17.4 million at Trulieve Cannabis, up from -$16.2 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $177.7 million in Q4 2021 and troughed at -$161.1 million in Q4 2022.
  • A 5-year average of -$7.5 million and a median of $599457.5 in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 3220.0% in 2022 and later crashed 14687.1% in 2023.
  • Year by year, Gains from Investment Securities stood at $177.7 million in 2021, then tumbled by 190.67% to -$161.1 million in 2022, then surged by 90.98% to -$14.5 million in 2023, then grew by 18.73% to -$11.8 million in 2024, then skyrocketed by 247.52% to $17.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for TCNNF at $17.4 million in Q4 2025, -$16.2 million in Q3 2025, and $5.3 million in Q2 2025.